Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Rigel Pharmaceuticals (RIGL) SEC Filings & 10K Form

Rigel Pharmaceuticals logo
$38.85 -0.46 (-1.17%)
Closing price 04:00 PM Eastern
Extended Trading
$38.52 -0.33 (-0.85%)
As of 05:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Rigel Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
08/14/2025
8:31 PM		ARMISTICE CAPITAL, LLC (Filed by)
Rigel Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
08/06/2025
5:03 AM		Rigel Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/28/2025
4:26 PM		Frohlich Mark W (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2025
4:26 PM		HANNAH ALISON L. (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2025
4:27 PM		LAPOINTE ANTHONY GREGG (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2025
4:27 PM		MOOS WALTER H (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2025
4:27 PM		Ali-Jackson Kamil (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2025
4:27 PM		Rigel Pharmaceuticals (Issuer)
Wasman Jane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
8:35 AM		BlackRock, Inc. (Filed by)
Rigel Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
04/10/2025
3:06 PM		Rigel Pharmaceuticals (Filer)
Form DEF 14A
04/10/2025
3:07 PM		Rigel Pharmaceuticals (Filer)
Form DEFA14A
04/10/2025
3:10 PM		Rigel Pharmaceuticals (Filer)
Form ARS
03/27/2025
8:16 AM		Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2025
7:55 PM		Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:56 PM		Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:56 PM		Rigel Pharmaceuticals (Issuer)
Rojkjaer Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:56 PM		Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:56 PM		Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:41 PM		Frohlich Mark W (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/10/2025
4:42 PM		Frohlich Mark W (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:22 PM		Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
4:18 PM		ARMISTICE CAPITAL, LLC (Filed by)
Rigel Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/07/2025
12:42 PM		Invesco Ltd. (Filed by)
Rigel Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/06/2025
7:26 PM		Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
7:27 PM		Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
7:27 PM		Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
7:27 PM		Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
2:40 PM		Rigel Pharmaceuticals (Subject)
RODRIGUEZ RAUL R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2025
2:41 PM		Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2025
2:43 PM		Rigel Pharmaceuticals (Subject)
Schorno Dean L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2025
2:58 PM		Rigel Pharmaceuticals (Subject)
Santos David A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2025
12:23 PM		BlackRock, Inc. (Filed by)
Rigel Pharmaceuticals (Subject)
Form SCHEDULE 13G
02/04/2025
3:39 PM		Rigel Pharmaceuticals (Subject)
Schorno Dean L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/04/2025
3:30 PM		Rigel Pharmaceuticals (Subject)
RODRIGUEZ RAUL R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/04/2025
3:20 PM		Rigel Pharmaceuticals (Subject)
Santos David A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/04/2025
3:21 PM		Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
5:47 PM		Rigel Pharmaceuticals (Issuer)
Rojkjaer Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
5:45 PM		Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
5:47 PM		Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
5:47 PM		Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
5:47 PM		Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This is my Christian duty (Ad)

“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.tc pixel

Watch Jim Rickards reveal the Old Testament Wealth Code
01/28/2025
7:49 PM		Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2025
3:38 PM		Masuda Esteban (Reporting)
Rigel Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
7:15 AM		Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
7:01 PM		Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
7:01 PM		Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
7:01 PM		Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
8:33 AM		Invesco Ltd. (Filed by)
Rigel Pharmaceuticals (Subject)
Form SC 13G
11/07/2024
3:22 PM		Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
3:01 PM		Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2024
7:36 PM		Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
7:33 PM		Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
7:30 AM		Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:RIGL) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...
Paradigm Press | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsoredtc pixel
Out of 18,347 Cryptocurrencies... This is the ONLY One
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...
Crypto 101 Media | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsoredtc pixel